DNASE1 and inflammatory bowel disease: When DNase-NZ was treated to dextran sulfate sodium (DSS)-induced animal model of IBD, various pathophysiological characteristics of IBD were improved by attenuating neutrophil infiltration and NETosis in the colon compared to those treated with free DNase-I or mesalamine (Scheme 1b).